Process and outcome differences in the care of patients undergoing elective and emergency right hemicolectomy von Banks, J, Rashid, A, Wilson, T R, Challand, C P, Lee, M J

Volltext

The morbidity of negative appendicectomy von Lee, M, Paavana, T, Mazari, F, Wilson, T R

Volltext

Screening for malnutrition in emergency laparotomy patients: a comparison of three tools von O'Connor, T, MacKenzie, L, Clarke, R W, Bradburn, M, Wilson, T R, Lee, M J

Volltext

c-FLIP inhibits chemotherapy-induced colorectal cancer cell death von LONGLEY, D. B, WILSON, T. R, MCEWAN, M, ALLEN, W. L, MCDERMOTT, U, GALLIGAN, L, JOHNSTON, P. G

Volltext

Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIP von Galligan, Leeona, Longley, Daniel B, McEwan, Miranda, Wilson, Timothy R, McLaughlin, Kirsty, Johnston, Patrick G

Volltext

Abstract P2-08-02: Interaction of PIK3CA mutation subclasses with response to preoperative treatment with the PI3K inhibitor pictilisib in patients with estrogen receptor-positive... von Schmid, P, Pinder, S, Wheatley, D, Zummit, C, Macaskill, EJ, Hu, J, Price, R, Bundred, N, Hadad, S, Shia, A, Sarker, S-J, Lim, L, Mousa, K, O'Brien, C, Wilson, TR, Lackner, MR, Gendreau, S, Gazinska, P, Korbie, D, Trau, M, Mainwaring, P, Thompson, A, Purushotham, A

Volltext

Abstract P6-12-01: Phase II study of taselisib (GDC-0032) plus fulvestrant in HER2-negative, hormone receptor-positive advanced breast cancer: Analysis by PIK3CA and ESR1 mutation... von Dickler, MN, Saura, C, Oliveira, M, Richards, DA, Krop, IE, Cervantes, A, Stout, TJ, Jin, H, Savage, HM, Wilson, TR, Baselga, J

Volltext

Abstract OT2-01-01: SANDPIPER: Phase III study of the PI3-kinase inhibitor taselisib (GDC-0032) plus fulvestrant in patients with estrogen receptor-positive, HER2-negative locally... von Baselga, J, Cortés, J, De Laurentiis, M, Dent, S, Diéras, V, Harbeck, N, Hsu, J, Jin, H, Schimmoller, F, Wilson, TR, Im, Y-H, Jacot, W, Krop, IE, Verma, S

Volltext

Abstract P6-07-08: The complete spectrum of ESR1 mutations from 7590 breast cancer tumor samples von Spoerke, JM, Schleifman, E, Clark, TA, Young, G, Nahas, M, Kennedy, M, Young, L, Chmielecki, J, Otto, GA, Lipson, D, Wilson, TR, Gendreau, S, Lackner, MR

Volltext

Abstract PD5-04: Ki67 changes and PEPI score in the LORELEI trial: A phase II randomized, double-blind study of neoadjuvant letrozole plus taselisib versus letrozole plus placebo i... von de Azambuja, E, Saura, C, Nuciforo, P, Frantal, S, Oliveira, M, Zardavas, D, Jallitsch-Halper, A, de la Pena, L, Dubsky, P, Lombard, JM, Vuylsteke, P, Castaneda Altamirano, C, Sanchez, C, Ballestrero, A, Colleoni, M, Santos Borges, G, Ciruelos, E, Bardia, A, Fornier, M, Boer, K, Wilson, TR, Stout, TJ, Hsu, JY, Shi, Y, Piccart, M, Baselga, J, Gnant, M

Volltext

Abstract OT1-03-14: SANDPIPER: Phase III study of the PI3-kinase inhibitor taselisib (GDC-0032) plus fulvestrant in patients with estrogen receptor-positive, HER2-negative locally... von Baselga, J, Cortés, J, De Laurentiis, M, Diéras, V, Harbeck, N, Hsu, J, Jin, H, Schimmoller, F, Wilson, TR, Im, Y-H, Jacot, W, Krop, IE, Verma, S

Volltext

Abstract PD3-04: PAK-1 amplified breast cancer cell lines are preferentially sensitive to PAK inhibition with G-5555 von Ong, CC, Blackwood, E, Jakubiak, D, Daemen, A, Ramaswamy, S, Heise, C, Schmidt, M, Sanders, L, Wilson, TR, Huw, L, Ndubaku, C, Rudolph, J, Hoeflich, KP, Friedman, L, O'Brien, T

Volltext

Abstract PD1-1: PI3-kinase mutations in recurrences in patients with estrogen receptor positive breast cancer von Dixon, JM, Renshaw, L, Keys, J, Sims, A, Thomas, J, Wilson, TR, Lackner, MR

Volltext

Abstract P6-05-09: Development of a predictive biomarker gene expression signature for the PIK3CA inhibitor, GDC-0032, in breast cancer cells von Savage, H, O'Brien, C, Spoerke, J, Huw, L, Wallin, J, Friedman, L, Lackner, MR, Wilson, TR

Volltext

Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population von Westphalen, C, Krebs, Matthew, Le Tourneau, Christophe, Sokol, ES, Maund, SL, Wilson, TR, Jin, DX, Newberg, JY, Fabrizio, D, Veronese, L, Thomas, M, de Braud, F

Volltext

The impact of a school entry law on adolescent immunization rates von Wilson, Thad R., Fishbein, Daniel B., Ellis, Peggy A., Edlavitch, Stanley A.

Volltext

Abstract P6-05-12: Comprehensive molecular analysis of estrogen receptor positive breast cancer to determine clinically actionable alterations von O'Brien, C, Savage, H, Huw, L, Fumagalli, D, Salgado, R, Criscitello, C, Pugliano, L, Laios, I, Piccart, M, Michiels, S, Sotiriou, C, Loi, S, Lackner, MR, Wilson, TR

Volltext

Abstract PD1-3: Ph1b study of the PI3K inhibitor GDC-0032 in combination with fulvestrant in patients with hormone receptor-positive advanced breast cancer von Juric, D, Saura, C, Cervantes, A, Kurkjian, C, Patel, MR, Sachdev, J, Mayer, I, Krop, IE, Oliveira, M, Sanabria, S, Cheeti, S, Lin, RS, Graham, RA, Wilson, TR, Parmar, H, Hsu, JY, Von Hoff, DD, Baselga, J

Volltext

Ileitis in Ulcerative Colitis: Is It a Backwash? von Abdelrazeq, Ayman S, Wilson, Timothy R, Leitch, Derek L, Lund, Jonathan N, Leveson, Stephen H

Volltext

The Roles of Thymidylate Synthase and p53 in Regulating Fas-Mediated Apoptosis in Response to Antimetabolites von LONGLEY, Daniel Broderick, ALLEN, Wendy Louise, MCDERMOTT, Ultan, WILSON, Timothy Richard, LATIF, Tariq, BOYER, John, LYNCH, Maria, JOHNSTON, Patrick Gerard

Volltext